| Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites (NCT05745233) | China Medical University Hospital | 2021-01-01 |
| Malignant Ascites Alfapump® Study (NCT04076566) | Sequana Medical N.V. | 2020-05-31 |
| Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites (NCT04051112) | Sichuan Clover Biopharmaceuticals, Inc. | 2019-09-28 |
| A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites (NCT03736122) | BioSyngen Pte Ltd | 2019-01-01 |
| A Study of M701 (EpCAM and CD3) in Malignant Ascites (NCT04501744) | Wuhan YZY Biopharma Co., Ltd. | 2018-09-30 |
| EUS-Guided Drainage of Refractory Malignant Ascites (NCT03550560) | Hospital Universitario Virgen Macarena | 2018-09-01 |
| Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites (NCT03200106) | Sequana Medical N.V. | 2017-08-01 |
| Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics (NCT04032600) | Charite University, Berlin, Germany | 2017-08-01 |
| Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites (NCT03230708) | Hui ting Xu，MD | 2017-05-01 |
| Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter. (NCT02724683) | Maciej Stukan, MD, PhD | 2016-01-01 |
| A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites (NCT02530398) | Dongfang Hospital Beijing University of Chinese Medicine | 2015-07-01 |
| Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites (NCT02496286) | Eastern Regional Medical Center | 2015-06-01 |
| Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02122185) | University of Chicago | 2015-02-25 |
| Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion (NCT01854866) | Huazhong University of Science and Technology | 2013-05-01 |
| ALFApump System Post Marketing Surveillance Registry (NCT01532427) | Sequana Medical N.V. | 2012-06-01 |
| Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites (NCT01327235) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2011-03-01 |
| Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion (NCT01262612) | Radboud University Medical Center | 2010-04-01 |
| Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers (NCT01200121) | AIO-Studien-gGmbH | 2010-02-01 |
| A Study of Bevacizumab to Prevent Malignant Ascites (NCT00908219) | Baylor College of Medicine | 2009-07-01 |
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers (NCT00822809) | Neovii Biotech | 2008-12-01 |
| Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites (NCT00326885) | Neovii Biotech | 2006-06-01 |
| Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group (NCT00836654) | Neovii Biotech | 2004-09-01 |
| EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer (NCT00028782) | National Cancer Institute (NCI) | 2001-10-01 |